Patents by Inventor Bjoern Biedermann

Bjoern Biedermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Siglec-9 binding agents
    Patent number: 9265826
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 23, 2016
    Assignee: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • Siglec-9 Binding Agents
    Publication number: 20160000908
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Application
    Filed: March 12, 2013
    Publication date: January 7, 2016
    Applicant: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • Siglec-9 Binding Agents
    Publication number: 20130302317
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Application
    Filed: March 12, 2013
    Publication date: November 14, 2013
    Applicant: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • Siglec-9 Binding Agents
    Patent number: 8394382
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: March 12, 2013
    Assignee: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • SingleC-9 Binding Agents
    Publication number: 20110104149
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Application
    Filed: September 16, 2010
    Publication date: May 5, 2011
    Applicant: University Court of the University of Dundee
    Inventors: Paul Richard Crocker, Bjoern Biedermann, David Bowen
  • SINGLEC-9 BINDING AGENTS
    Publication number: 20090220509
    Abstract: The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.
    Type: Application
    Filed: October 27, 2006
    Publication date: September 3, 2009
    Inventors: Paul Richard Crocker, Bjoern Biedermann